Cargando…
Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to Cure
PURPOSE OF REVIEW: Hepatitis C (HCV) is the most common cause of viral hepatitis in elderly individuals. This patient population previously experienced suboptimal outcomes with interferon-based regimens. Unfortunately, patients aged 65 years and older were underrepresented in phase 2 and 3 clinical...
Autores principales: | Mohammed Abdul, Mubeen Khan, Snyder, Heather S., Chunduru, Mythili, Lee, Susan M.K., Satapathy, Sanjaya K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418288/ https://www.ncbi.nlm.nih.gov/pubmed/32837340 http://dx.doi.org/10.1007/s40506-020-00231-8 |
Ejemplares similares
-
Building a Hepatitis C Clinical Program: Strategies to Optimize Outcomes
por: Zuckerman, Autumn, et al.
Publicado: (2018) -
A Review of the Diagnosis and Management of Hepatitis E
por: Kar, P., et al.
Publicado: (2020) -
Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C
por: Sherigar, Jagannath M., et al.
Publicado: (2017) -
Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus
por: van de Ven, Nikolien, et al.
Publicado: (2015) -
Peripheral neuropathy after viral eradication with direct‐acting antivirals in chronic HCV hepatitis: A prospective study
por: Zanone, Maria M., et al.
Publicado: (2021)